Artiva Biotherapeutics, Inc.ARTVNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-84M

-43.4% YoY

Free Cash Flow

$-79M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	2	5↑146.3%	33↑579.2%	0↓99.3%	0
Gross Profit	2	5↑146.3%	33↑579.2%	0↓99.3%	-3↓1134.7%
Operating Income	-53	-60↓12.3%	-31↑48.7%	-67↓119.4%	-91↓34.7%
Net Income	-72	-58↑18.7%	-28↑52.6%	-58↓111.2%	-84↓43.4%
EBITDA	-72	-59↑18.0%	-28↑51.6%	-65↓128.3%	-88↓35.7%
EPS Diluted	-4.08	-3.32↑18.6%	-1.19↑64.2%	-5.20↓337.0%	-3.43↑34.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	161	103↓36.3%	54↓47.8%	40↓24.8%	27↓33.6%
Total Current Assets	162	105↓35.5%	80↓23.7%	189↑136.3%	113↓40.3%
Total Assets	170	133↓21.7%	105↓21.0%	210↑99.4%	131↓37.5%
Total Current Liabilities	19	26↑32.7%	12↓52.3%	12↑0.2%	13↑6.8%
Total Liabilities	259	274↑5.8%	267↓2.4%	23↓91.4%	21↓8.6%
Total Equity	-89	-141↓58.3%	-162↓15.2%	187↑215.2%	110↓41.1%
Total Debt	2	19↑1017.1%	17↓13.0%	14↓15.1%	11↓23.8%
Net Debt	-159	-83↑47.8%	-37↑56.0%	-26↑29.3%	-16↑39.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-15	-51↓232.1%	-47↑6.7%	-55↓16.0%	-77↓39.5%
Capital Expenditure	-2	-6↓265.4%	-3↑48.3%	-1↑80.3%	-3↓303.0%
Free Cash Flow	-17	-57↓235.5%	-51↑11.3%	-56↓9.8%	-79↓42.5%
Stock-Based Comp	4	7↑52.9%	7↑7.1%	7↓1.0%	7↓2.3%
Net Change in Cash	136	-58↓143.0%	-49↑16.1%	-13↑72.9%	-13↓0.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance